Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real-World Data Approach

Area of Science:

• Medical research
• Genetics
• Pediatrics

Background:

• Metachromatic leukodystrophy (MLD) is a rare genetic disorder characterized by neurodegeneration.
• Systemic complications can precede neurological symptoms, impacting early diagnosis and eligibility for emerging gene therapies.

Purpose of the Study:

• To characterize pre-diagnosis systemic complications in MLD to identify barriers to early diagnosis.
• To analyze the time to diagnosis (TTD) based on various organ-system clusters and patient demographics.
• To inform strategies for earlier MLD screening and intervention.

Main Methods:

• Utilized medical billing (claims) datasets and a natural history study to identify MLD cases and pre-diagnosis events.
• Aggregated MLD-related ICD-10-CM codes into system-based diagnosis clusters.
• Computed TTD and compared diagnostic delays by sex and insurance type using survival analysis.

Main Results:

• Common pre-diagnosis events included general neurological concerns, gastrointestinal issues, seizures, ophthalmologic problems, and language difficulties.
• Children with non-commercial insurance experienced longer TTD, particularly for seizures and non-degenerative neurological symptoms.
• Analysis of claims and natural history data revealed similar patterns of prodromal symptoms and diagnostic delays.

Conclusions:

• This study defines significant barriers to timely MLD diagnosis, highlighting prodromal symptomatology before neurodegeneration.
• Delayed diagnosis, influenced by insurance type, hinders access to potentially life-saving gene therapies.
• Emphasizes the critical need for enhanced early screening protocols for MLD in at-risk children.